Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published online before print August 6, 2009
Psychosom Med 2009, doi:10.1097/PSY.0b013e3181b39aa1
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Francis, J. L.
Right arrow Articles by Kop, W. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francis, J. L.
Right arrow Articles by Kop, W. J.
Related Collections
Right arrow Anxiety
Right arrow Parasympathetic Nervous System
Right arrow Depression
Right arrow Sympathetic Nervous System
© 2009 by American Psychosomatic Society

Original Article


Received October 16, 2008
Returned for revision May 1, 2009

Association Between Symptoms of Depression and Anxiety With Heart Rate Variability in Patients With Implantable Cardioverter Defibrillators

Jennifer L. Francis , PhD, Ali A. Weinstein , PhD, David S. Krantz , PhD, Mark C. Haigney , MD, Phyllis K. Stein , PhD, Peter H. Stone , MD, John S. Gottdiener , MD, Willem J. Kop , PhD


Address correspondence and reprint requests to: Willem J. Kop, PhD, E-mail: wkop{at}medicine.umaryland.edu.


  Abstract

Objective: This study investigated whether depression and anxiety symptoms are associated with measures of autonomic nervous system dysfunction in patients with implantable cardioverter defibrillators who are at high risk of cardiac rhythm disturbances. Depression and anxiety are associated with autonomic nervous system dysfunction, which may promote the risk of malignant cardiac arrhythmias. Methods: Patients with an implantable cardioverter defibrillator (ICD) underwent ambulatory electrocardiographic (ECG) monitoring (n = 44, mean age = 62.1 ± 9.3 years). Depression was assessed using the Beck Depression Inventory and anxiety was evaluated using the Taylor Manifest Anxiety Scale. Heart rate variability was assessed using time (RMSSD, pNN50, and SDNN) and frequency domain measures derived from 24-hour R-R intervals. Multivariate models were adjusted for age, sex, hypertension, diabetes, and smoking status. Results: Defibrillator patients with elevated depression symptoms (n = 12) had significantly lower RMSSD (15.25 ± 1.66 ms versus 24.97 ± 2.44 ms, p = .002) and pNN50 (1.83 ± 0.77 versus 5.61 ± 1.04, p = .006) than defibrillator patients with low depression symptoms (n = 32). These associations remained significant after multivariate adjustment for covariates. ICD patients with high anxiety levels (n = 10) displayed lower RMSSD (p = .013), which became marginally significant when adjusting for covariates (p = .069). Conclusions: Depression and anxiety in defibrillator patients are associated with autonomic nervous system dysfunction indices of reduced parasympathetic control. Autonomic nervous system dysfunction may partially explain the association between depression and anxiety with life-threatening cardiac outcomes in vulnerable patients.

Key Words: depression, anxiety, autonomic nervous system, heart rate variability, implantable cardioverter defibrillator






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the American Psychosomatic Society